Trial intelligence / Profile preview

Outcome of Platelet Rich Plasma Injection in ICSI Patients

NCT04434495Phase 2Unknown

Sponsor
Dr. Osman Hospital
Start
Jun 2020
Primary completion
Nov 2020
Modality
Adoptive Cell Transfer
01

Overview

Phase 2, randomised, double-blind trial of autologous platelet-rich plasma in infertility (2 arms), sponsored by Dr. Osman Hospital. Primary endpoint: Clinical pregnancy rate at 4 weeks. Status: unknown.

02

Drugs

autologous platelet-rich plasma
03

Conditions

infertility

Beyond the preview

Go deeper on NCT04434495.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04434495.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call